ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

A New Study Supports Shoes As A Source of Pain Relief

By: NewsUSA

(NewsUSA) - One in four American adults suffers from chronic knee pain, so an accessible, non-surgical solution should come as welcome news.

A recent study out of UCLA indicates that GDEFY® medically engineered shoes could be that solution. In fact, study participants wearing the GDEFY shoes with patented VersoShock® technology reported an average reduction in knee pain of 85%, as well as significant decreases in other common conditions.

A double-blind, randomized study conducted at Olive View UCLA Medical Center, recently published in the Journal of the American Podiatric Medical Association, shows that wearing shoes with VersoShock soles decreases knee pain by up to 85% vs. wearing shoes with conventional soles during prolonged standing and walking. After five weeks, participants using the GDEFY intervention sole shoe -- with shock-absorbing VersoShock technology -- reported an average reduction in knee pain of 85%, significantly better than participants using the traditional sole shoe (P < .01), whose average pain scores increased. Also observed were positive effects on back, ankle and foot pain in those with the intervention sole shoe, compared with the traditional sole shoe.

Alexander Elnekaveh founded Gravity Defyer Medical Technology Corporation in 2008 after his 14-year-old nephew was diagnosed with a cancerous growth in his heel. Even after successful heel surgery, physical therapy and help from leading doctors in pain management, Elnekaveh's nephew had little chance of walking pain-free again. But Elnekaveh, an inventor, wasn't satisfied with that prognosis, so he assembled a team of top podiatrists, physical therapists, biochemical and material engineers (Impact Research Technology Group) to help him develop the first Gravity Defyer (GDEFY) shoe with VersoShock technology.

"Our mission is to maximize comfort and boost performance for people who have foot biomechanics that keep them from walking properly and to enable normal pronation," says Elnekaveh.

"This study proves what we've known all along: that our breakthrough VersoShock technology provides the ultimate pain relief in a way no other shoe can."

To accommodate customers at work, home and play, GDEFY men's and women's footwear comes in several styles, widths and sizes. All shoes come with a polyurethane removable insole to adjust to one's comfort preference.

GDEFY footwear is available online at www.gdefy.com or in GDEFY stores throughout the country, as well as in most premium independent shoe retailers, including The Walking Company, Nordstrom, DSW and Dillard's. GDEFY continues to expand its presence, bringing pain-relieving footwear closer to feet everywhere.

 

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+4.06 (1.77%)
AAPL  278.85
+1.30 (0.47%)
AMD  217.53
+3.29 (1.54%)
BAC  53.65
+0.66 (1.25%)
GOOG  320.12
-0.16 (-0.05%)
META  647.95
+14.34 (2.26%)
MSFT  492.01
+6.51 (1.34%)
NVDA  177.00
-3.26 (-1.81%)
ORCL  201.95
-3.01 (-1.47%)
TSLA  430.17
+3.59 (0.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.